Cargando…

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors

Immune microenvironment in gastric cancer is closely associated with patient’s prognosis. Long non-coding RNAs (lncRNAs) are emerging as key regulators of immune responses. In this study, we aimed to construct a prognostic model based on immune-related lncRNAs (IRLs) to predict the overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Zuoyou, Li, Ran, Han, Jun, Sun, Diya, Shen, Lei, Wu, Guohao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548421/ https://www.ncbi.nlm.nih.gov/pubmed/34722522 http://dx.doi.org/10.3389/fcell.2021.739583

Ejemplares similares

Comprehensive Analysis of an Individualized Immune-Related lncRNA Pair Signature in Gastric Cancer
por: Nie, Chuang, et al.
Publicado: (2022)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Identification and Comprehensive Prognostic Analysis of a Novel Chemokine-Related lncRNA Signature and Immune Landscape in Gastric Cancer
por: Liang, Xiaolong, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

A Novel DNA Repair Gene Signature for Immune Checkpoint Inhibitor-Based Therapy in Gastric Cancer
por: Yuan, Binbin, et al.
Publicado: (2022)

A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint Inhibitors
por: Lu, Yi, et al.
Publicado: (2022)

Role of an Exosomes-Related lncRNAs Signature in Tumor Immune Microenvironment of Gastric Cancer
por: Li, Chan, et al.
Publicado: (2022)

Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer
por: Dai, Shuang, et al.
Publicado: (2021)

Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer
por: Hu, Wei, et al.
Publicado: (2021)

Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer
por: Zhang, Qiyao, et al.
Publicado: (2021)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
por: Zhang, Peiling, et al.
Publicado: (2021)

LncRNA and its role in gastric cancer immunotherapy
por: Zhang, Qiang, et al.
Publicado: (2023)

Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
por: Guo, Chunguang, et al.
Publicado: (2022)

Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
por: Ding, Hongmei, et al.
Publicado: (2022)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
por: Sun, Yueqin, et al.
Publicado: (2021)

TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer
por: Cui, Lin, et al.
Publicado: (2021)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma
por: Sun, Shuya, et al.
Publicado: (2022)

lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer
por: Nai, Aitao, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
por: Deng, Jingjing, et al.
Publicado: (2022)

Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
por: Geng, Wei, et al.
Publicado: (2021)

Assessing the Regulatory Functions of LncRNA SNHG11 in Gastric Cancer Cell Proliferation and Migration
por: Zhao, Danyi, et al.
Publicado: (2021)

Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma
por: Kang, Wenjuan, et al.
Publicado: (2021)

Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma
por: Chen, Zhuohui, et al.
Publicado: (2021)

A Prognostic Ferroptosis-Related lncRNAs Signature Associated With Immune Landscape and Radiotherapy Response in Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma
por: Liu, Jing, et al.
Publicado: (2020)

Identification and Analysis of An Epigenetically Regulated Five-lncRNA Signature Associated With Outcome and Chemotherapy Response in Ovarian Cancer
por: Yang, Hao, et al.
Publicado: (2021)

Characterization of lncRNA-Perturbed TLR-Signaling Network Identifies Novel lncRNA Prognostic Biomarkers in Colorectal Cancer
por: Chu, Yanjie, et al.
Publicado: (2020)

The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
por: Xie, Deqian, et al.
Publicado: (2023)

Dynamic Transcriptome Profiling Reveals LncRNA-Centred Regulatory Networks in the Modulation of Pluripotency
por: Wang, Shen, et al.
Publicado: (2022)

Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer
por: Jiang, Tongchao, et al.
Publicado: (2023)

Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes
por: Shen, Xiaoyan, et al.
Publicado: (2022)

Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
por: Cassetta, Luca, et al.
Publicado: (2018)

The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer
por: Shao, Wei, et al.
Publicado: (2021)

Fucoidan-Supplemented Diet Potentiates Immune Checkpoint Blockage by Enhancing Antitumor Immunity
por: Yang, Juan, et al.
Publicado: (2021)

LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers
por: Yuan, Xin, et al.
Publicado: (2022)

Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer
por: Song, Shenglei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pq7oul96ad9h119dnfhti1kvht